Screener
Orthofix Medical Inc. OFIX Global Limb Reconstruction — D&A
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Orthofix Medical Inc. in its filing.
Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.
The source filing: Orthofix Medical Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 7:06 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333822
| (Unaudited, U.S. Dollars, in thousands) | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Global Spine | $9,986 | $14,851 | $20,204 | $46,753 |
| Global Limb Reconstruction | 2,807 | 1,419 | 5,585 | 3,355 |
| Corporate | 480 | 601 | 977 | 1,194 |
| Total | $13,273 | $16,871 | $26,766 | $51,302 |
Item 1. Financial Statements
FAQ
- What is Orthofix Medical Inc.'s global limb reconstruction — D&A?
- Orthofix Medical Inc. (OFIX) reported global limb reconstruction — D&A of $2.81M in Q2 2026.
- How has Orthofix Medical Inc.'s global limb reconstruction — D&A changed year-over-year?
- Orthofix Medical Inc.'s global limb reconstruction — D&A increased by 97.8% year-over-year, from $1.42M to $2.81M.
- What does global limb reconstruction — D&A mean?
- This metric reflects the non-cash allocation of the cost of tangible and intangible assets associated with the limb reconstruction segment over their useful lives. It is a critical component for understanding the capital intensity and reinvestment requirements of the segment.
Ask your AI about Orthofix Medical Inc.'s global limb reconstruction — d&a.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude